#National Cancer Institute

We’re interested in assessing how diet affects health—but in the context of the what, where, when, why, and how we eat.

This is, without a doubt, a time of great hope in cancer research.

In non-small cell lung cancer, new drugs like brigatinib and crizotinib can dramatically shrink tumors with an ALK alteration.

The dual-stain test addresses a critical question: How often should HPV-positive women undergo repeat screenings for cervical cancer?

The program proved as accurate as experienced pathologists at diagnosing adenocarcinomas and squamous cell carcinomas.

Because so few people diagnosed with SCLC survive for even a year despite treatment, an advance in survival rate is quite significant.

The lead researcher called the results “tantalizing, but not yet good enough.”

A win–win for making progress against cancer

Certain cancer treatments can damage the heart and the cardiovascular system.

Scientists at Division of Cancer Prevention and the Center for Global Health collaborate to to study cancers nationally and internationally.

A conversation with Supriya Mohile, MD

Though researchers knew that exosomes play important roles in cancer and in the immune system, only now are they learning the specifics.

“It stands to reason that we should develop treatments specifically for appendix cancer.”

The plan represents our best judgement on the optimum funding needed to make the most rapid progress against cancer.

The inventory will enable researchers to find potential collaborations, increasing our understanding of the causes of childhood cancers.

The researchers hope to develop a clinical trial to combine arsenic with the standard therapy for women with triple-negative breast cancer.